Marin-Acevedo JA - Search Results

1

Defining the needle in a haystack: A compendium of genomic, pathologic, and clinical characteristics of rare pulmonary tumors.

Shields MD, Minton KG, Tran M, Gunderman PR, Larsson LG, Guo S, Kniese CM, Wei CX, Marin-Acevedo JA, Maniar R, Durm GA, He W, Hanna NH. Shields MD, et al. Among authors: marin acevedo ja. Lung Cancer. 2024 Dec 27;199:108035. doi: 10.1016/j.lungcan.2024.108035. Online ahead of print. Lung Cancer. 2024. PMID: 39731864 Review.

2

Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).

Kimbrough EO, Marin-Acevedo JA, Drusbosky LM, Mooradian A, Zhao Y, Manochakian R, Lou Y. Kimbrough EO, et al. Among authors: marin acevedo ja. Cancers (Basel). 2024 Jun 27;16(13):2366. doi: 10.3390/cancers16132366. Cancers (Basel). 2024. PMID: 39001428 Free PMC article.

3

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma.

Marin-Acevedo JA, Withycombe BM, Kim Y, Brohl AS, Eroglu Z, Markowitz J, Tarhini AA, Tsai KY, Khushalani NI. Marin-Acevedo JA, et al. Cancers (Basel). 2023 Jun 14;15(12):3180. doi: 10.3390/cancers15123180. Cancers (Basel). 2023. PMID: 37370790 Free PMC article.

4

Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data.

Marin-Acevedo JA, Pellini B, Kimbrough EO, Hicks JK, Chiappori A. Marin-Acevedo JA, et al. Cancers (Basel). 2023 Jan 19;15(3):629. doi: 10.3390/cancers15030629. Cancers (Basel). 2023. PMID: 36765587 Free PMC article. Review.

5

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.

Schlick B, Shields MD, Marin-Acevedo JA, Patel I, Pellini B. Schlick B, et al. Among authors: marin acevedo ja. Curr Treat Options Oncol. 2022 Aug;23(8):1104-1120. doi: 10.1007/s11864-022-00989-7. Epub 2022 Jun 18. Curr Treat Options Oncol. 2022. PMID: 35716328 Free PMC article. Review.

6

Immunotherapies targeting stimulatory pathways and beyond.

Marin-Acevedo JA, Kimbrough EO, Manochakian R, Zhao Y, Lou Y. Marin-Acevedo JA, et al. J Hematol Oncol. 2021 May 12;14(1):78. doi: 10.1186/s13045-021-01085-3. J Hematol Oncol. 2021. PMID: 33980266 Free PMC article. Review.

7

Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress.

Shields MD, Marin-Acevedo JA, Pellini B. Shields MD, et al. Among authors: marin acevedo ja. Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-23. doi: 10.1200/EDBK_321483. Am Soc Clin Oncol Educ Book. 2021. PMID: 33979196 Free article.

8

Next generation of immune checkpoint inhibitors and beyond.

Marin-Acevedo JA, Kimbrough EO, Lou Y. Marin-Acevedo JA, et al. J Hematol Oncol. 2021 Mar 19;14(1):45. doi: 10.1186/s13045-021-01056-8. J Hematol Oncol. 2021. PMID: 33741032 Free PMC article. Review.

9

In Reply - Immune Checkpoint Inhibitor-Induced Type 1 Diabetes: An Underestimated Risk.

Marin-Acevedo JA, Chirila RM, Dronca R. Marin-Acevedo JA, et al. Mayo Clin Proc. 2020 Mar;95(3):615. doi: 10.1016/j.mayocp.2019.12.010. Mayo Clin Proc. 2020. PMID: 32138892 No abstract available.

10

Ocular Tuberculosis.

Marin-Acevedo JA, Chirila RM, Cowart JB. Marin-Acevedo JA, et al. J Gen Intern Med. 2019 Oct;34(10):2288-2289. doi: 10.1007/s11606-019-05129-w. Epub 2019 Jul 24. J Gen Intern Med. 2019. PMID: 31342323 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters